Related Experiment Video
Updated: Aug 21, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Effects of intrapartum penicillin prophylaxis on intestinal bacterial colonization in infants
Françoise Jauréguy1, Mathieu Carton, Pierre Panel
1Microbiologie, UFR des Sciences Pharmaceutiques et Biologiques, 75270 Paris Cedex 06, France.
Insights
Intrapartum antibiotic prophylaxis (IAP) for early-onset group B streptococcal infections did not increase resistant bacteria in infants. However, it did reduce initial colonization by anaerobic bacteria like Clostridium.
Area of Science:
- Microbiology
- Neonatal Health
- Infectious Disease Prevention
Background:
- Early-onset group B streptococcal (GBS) infections pose significant risks to newborns.
- Intrapartum antibiotic prophylaxis (IAP) is recommended to prevent GBS transmission.
- Concerns exist regarding IAP's potential to promote antibiotic resistance.
Purpose of the Study:
- To investigate the impact of intrapartum amoxicillin prophylaxis on the early gastrointestinal bacterial flora of infants.
- To determine if IAP influences the acquisition of antibiotic-resistant bacteria in neonates.
Main Methods:
- Stool samples were collected from 3-day-old infants exposed (n=25) and not exposed (n=25) to intrapartum amoxicillin.
- Groups were matched for gestational age, delivery type, and feeding method.
- Bacterial flora in stool samples underwent qualitative and quantitative differential analysis.
Main Results:
- No significant difference in aerobic bacteria or amoxicillin-resistant enterobacteria colonization between groups.
- Significantly lower colonization by anaerobic bacteria, particularly Clostridium, in the antibiotic-exposed group (12% vs. 40%).
- IAP did not promote beta-lactam-resistant bacteria colonization.
Conclusions:
- Intrapartum amoxicillin prophylaxis showed minimal impact on initial infant gut flora, with a notable reduction in Clostridium colonization.
- The study did not find evidence that IAP favors colonization by beta-lactam-resistant bacteria.
- Further research is needed to assess long-term risks associated with widespread antibiotic use for GBS prevention.
Abstract:
Early-onset group B streptococcal (GBS) infections remain a leading cause of morbidity and mortality in infants. To prevent the vertical transmission of GBS and neonatal GBS infection, guidelines recommend intrapartum penicillin or amoxicillin prophylaxis. This intrapartum antibiotic prophylaxis (IAP) is suspected to favor colonization by antibiotic-resistant bacteria. However, the effects of this prophylaxis on the patterns of acquisition of gastrointestinal bacterial flora in infants have never been studied. We collected stool samples from 3-day-old infants born to mothers who received intrapartum amoxicillin (antibiotic-exposed group; n = 25) and to untreated mothers (non-antibiotic-exposed group; n = 25). The groups were matched for factors known to affect intestinal microbial colonization: gestational age, type of delivery, and type of feeding. Qualitative and quantitative differential analyses of the bacterial flora in stool samples were performed. Similar numbers of infants in the non-antibiotic-exposed and antibiotic-exposed groups were colonized by aerobic bacteria and amoxicillin-resistant enterobacteria (75 and 77%, respectively) (P = 0.79). In contrast, significantly fewer infants in the antibiotic-exposed group than in the non-antibiotic-exposed group were colonized by anaerobic bacteria, especially Clostridium (12 and 40%, respectively) (P < 0.05). Regarding intestinal bacterial colonization, the differences between antibiotic-exposed and non-antibiotic-exposed infants were remarkably few. The only statistically significant effect was the reduced initial bacterial colonization by Clostridium in the antibiotic-exposed group. In our study, the use of IAP did not favor colonization by beta-lactam-resistant bacteria. However, further evaluations are required to highlight the potential risks of the widespread use of antibiotics to prevent early-onset GBS infection.
Related Concept Videos
Development of the Oral Microbiota
Microbiota Modulation by Antibiotics
Development of Human Microbiota
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Production of Antibiotics
Inhibitors of Gram-positive Cell Wall Synthesis

